Daxor Gross Profit 2010-2011 | DXR

Daxor gross profit from 2010 to 2011. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Daxor Annual Gross Profit
(Millions of US $)
2011 $1
2010 $1
2009 $1
Daxor Quarterly Gross Profit
(Millions of US $)
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.035B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.637B 19.35
Encompass Health (EHC) United States $11.786B 24.99
DaVita (DVA) United States $11.101B 15.33
Chemed (CHE) United States $8.326B 26.17
Elanco Animal Health (ELAN) United States $6.367B 13.64
Option Care Health (OPCH) United States $5.217B 23.25
RadNet (RDNT) United States $4.278B 271.57
Amedisys (AMED) United States $3.132B 21.06
LifeStance Health (LFST) United States $2.275B 0.00
Addus HomeCare (ADUS) United States $2.034B 22.33
Astrana Health (ASTH) United States $1.600B 39.64
U.S Physical Therapy (USPH) United States $1.175B 30.33
Aveanna Healthcare Holdings (AVAH) United States $1.128B 64.22
Pennant (PNTG) United States $1.019B 37.40
Atai Life Sciences (ATAI) Germany $0.288B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00